Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
5.223M
Cash
2.595M
Avg Qtr Burn
-863.7K
Short % of Float
1.26%
Insider Ownership
20.48%
Institutional Own.
8.88%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LB-100 +atezolizumab Details Cancer, Metastatic colorectal cancer | Phase 1 Data readout |